Navigation Links
Statement of Bernadette Toomey, President and Chief Executive Officer, American Lung Association
Date:3/12/2008

Half Measures and Compromises Are Not Good Enough

WASHINGTON, March 12 /PRNewswire-USNewswire/ -- Today, the U.S. Environmental Protection Agency announced a critical tightening of the health-based National Ambient Air Quality Standard for ozone. We wish we could be happier about this decision, but we cannot. The standard announced today, although an improvement, falls far short of the requirements of the Clean Air Act. We are unable to celebrate half measures when the risks are so evident, when the science and the scientists are so united about what is needed and when the missed opportunity means that thousands will suffer more and die sooner than they should. Furthermore, we reject the suggestions made by the Administrator to weaken and undermine the Clean Air Act itself. Coming from the head of the Environmental Protection Agency, such suggestions are truly outrageous.

Certainly, today's decision on the health-based standard opens a welcome new phase in the attack against the most widespread air pollutant in the nation -- and among the most dangerous. A tighter ozone standard sets in motion new steps to clean up air pollution. The ozone standard the EPA adopted strengthens the protection for millions of Americans from the air pollutant often known as smog. Yet, by stopping far short of the mark, the EPA action today denies millions more the protection they deserve from their government.

Ozone smog threatens the health of infants, children, seniors, and people who have asthma, emphysema, chronic bronchitis, and other lung diseases. For these people, breathing smog-polluted air can make them cough and wheeze, restrict their airways, worsen their diseases, force them to the hospital and even kill them. Even healthy young adults and people who exercise or work outdoors can suffer from high levels of ozone pollution.

Today's decision means that millions of Americans will not get the protection that the law requires. According
'/>"/>

SOURCE American Lung Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Developed by Opticom Data...vice for self-examination of the eye. , ...r 24, 2009 -- FloatScope is a new hand-held device...elp monitor various ocular health conditions such ...ns as well as the functioning of the iris., , , Fl...
(Date:11/23/2009)... A recent metobolomics study by researchers from V...Richmond found that impaired peroxisomal oxidation...ed with the progression of nonalcoholic fatty live... The study also found significantly higher plasma ...ts with NAFL and NASH. Full findings appear in th...
(Date:11/23/2009)... Same Day STD Testing now ...sts for all types of STD,s, including Chlamydia, H...e -- all done anonymously. , ...ing found on the web at: http://www.samedaystdtes...idential STD testing, which is now available to ac...
(Date:11/23/2009)..., ActingSecretaryEncouragesUseofPAPreferredPr...RNewswire-USNewswire/--Toensurethatyourfamilyhasas...taryRussellReddingisurgingresidentstofollowafewbas...tovers. ,, "Followingandunderstandingproperfood...akingsureyourThanksgivingdinnerissafetoeat,"saidRe...
(Date:11/23/2009)... Biomethylation of arsenic compounds appears to ca...cinogenicity, according to a new study published o...Cancer Institute . , Although biomethylation was...s now thought to enhance its toxicity and potentia...of arsenic biomethylation in oxidative DNA damage ...
Breaking Medicine News(10 mins):Health News:FloatScope - A New Device for Self-Viewing Eye Floaters 2Health News:Metobolomics uncovers key indicators of nonalcoholic fatty liver disease 2Health News:100% Anonymous, Confidential and Quick STD Screening Now Available with Same Day STD Testing 2Health News:Pennsylvania Agriculture Department Encourages Proper Food Handling, Offers Safety Tips for Thanksgiving 2
...logists, geneticists and neuroscientists has repor...ascular problems in the brain has improved spatial...Although far from proving anything about human use...t of normal aging, or even enhance learning and me...
...rocedure aids healing, experts say , , SU...umbers of baby boomers reaching retirement age, jo...more Americans. , But improved movement and lack...y faster and better. , Before going under the kn...
...,s Medical Center has been named one of the "2009...sionals magazine. , , The top 100 list acknowled... organizational levels in order to effectively ser... critical to patient care at the bedside and in th...
... 1 issue of the journal SLEEP shows that sleep d...f specific cytokines that are important in regulat...mation may be the pathway linking extreme sleep du...eactive protein (CRP) levels and a seven-percent i...
...tients Develop a Menu Game Plan , , EL SEGUNDO, C... kidney care services for those diagnosed with chr...rs kidney patients a chance to enjoy the benefits ...ging chronic kidney disease and ensuring patients,...
...ive practice plays a role, study suggests , ... regularly attend religious services may be less l...tudy suggests. , University of Manitoba researcher...ous worship and suicidal behavior. , "The main fin...
Other Medicine News:Health News:Vascular drug found to improve learning and memory in middle-aged rats 2Health News:A Checklist for Joint Replacement Surgery 2Health News:Study suggests that inflammation may be the link between extreme sleep durations and poor health 2Health News:DaVita.com Promotes Kidney-Friendly Foods for Super Bowl(R) XLIII 2Health News:DaVita.com Promotes Kidney-Friendly Foods for Super Bowl(R) XLIII 3
(Date:11/23/2009)....23/PRNewswire/--LigonDiscovery,Inc.,whichusesprop...sagainsthigh-valuetargets,todayannouncedtheappoint...sLigon,sExecutiveChairmanoftheBoard. ,, "I,mver...theBoard,"saidPatrickKleyn,Ligon,schiefexecutiveof...enceinthelifesciencesindustry--particularlyhislead...
(Date:11/23/2009)...ovalsoftwonewtherapiesforNon-Hodgkin,sLymphomas(NH...ofatumumab(Azerra(TM),GlaxoSmithKline)asatherapyop...andromidepsin(Istodax(R),GloucesterPharmaceuticals...lllymphoma(CTCL). ,, FORTWASHINGTON,Pa.,Nov.23/...romptedtheNationalComprehensiveCancerNetwork( NCCN...
(Date:11/23/2009)...wswire/--Reportlinker.comannouncesthatanewmarketre...calNonwovenDisposables-AWorldwideMarketReview ,...Nonwoven-Disposables---A-Worldwide-Market-Review.h...m_campaign=prnewswire ,, Withincreaseinrang...healthcareandhospitalfacilities,nonwovenshasemerge...
Breaking Medicine Technology:Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 3Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 2Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 3Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 4Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 5Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 6Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 7Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 8Arcadian Health Names Rick Click as New Chief Information Officer 58491 1Arcadian Health Names Rick Click as New Chief Information Officer 58491 2Cadence Pharmaceuticals CEO Ted Schroeder to Present at the JMP Securities Healthcare Focus Conference in New York on October 6 2009 58489 1Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 1Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 2Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 3Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 4Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 5Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 6
...x to Fund Human Clinical Trials, MINNEAPOLIS, Oct... $20 million Series B financing. Co-Founded in Jul...utonix is a medical device company,focused on the ...alloon,angioplasty technology for the treatment an...nosis caused by atherosclerosis. Lutonix,s drug co...
...es for the most common, pathogens, including meth...EINACH, Switzerland, Oct. 26 Arpida (SWX:,ARPN) t...al Phase III,clinical trials at the 48th Interscie...erapy (ICAAC)/Infectious Diseases Society of Ameri...n these studies, intravenous iclaprim, a,novel ant...
Other Medicine Technology:Lutonix Inc. Announces $20 Million Series B Financing 2Lutonix Inc. Announces $20 Million Series B Financing 3Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 2Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 3Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 4Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 5Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 6Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 7
...Med TruFlow™ Oxygen flowmeter with a Lexan&r...nty covering calibration and manufacturing defects...meet most needs. Also available with all popular i...f and double unit configurations. Our extra large ...
...Med TruFlow™ Oxygen flowmeter with a Lexan&r...nty covering calibration and manufacturing defects...meet most needs. Also available with all popular i...f and double unit configurations. Our extra large ...
...Med TruFlow™ Oxygen flowmeter with a Lexan&r...nty covering calibration and manufacturing defects...meet most needs. Also available with all popular i...f and double unit configurations. Our extra large ...
...ates to adults, the entire series of time-tested T...surpassed knowledge of the needs of care providers...y. You can see it in the craftsmanship. You can se...meter® Classic Flowmeter is hand-crafted and e...
Medicine Products: